US BANCORP \DE\ - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$60,735
-0.4%
678
-5.3%
0.00%
Q2 2023$60,960
-6.5%
716
-9.1%
0.00%
Q1 2023$65,207
+0.5%
788
-4.5%
0.00%
Q4 2022$64,886
-14.6%
825
-19.2%
0.00%
Q3 2022$76,000
-13.6%
1,021
-24.7%
0.00%
Q2 2022$88,000
-30.2%
1,356
-31.6%
0.00%
Q1 2022$126,000
+5.9%
1,983
-11.7%
0.00%
Q4 2021$119,000
-48.9%
2,246
-32.2%
0.00%
Q3 2021$233,000
+32.4%
3,314
+24.8%
0.00%
Q2 2021$176,000
-38.2%
2,655
+3.2%
0.00%
-100.0%
Q1 2021$285,000
-7.8%
2,572
-1.2%
0.00%0.0%
Q4 2020$309,000
+32.1%
2,603
-3.2%
0.00%0.0%
Q3 2020$234,000
-9.3%
2,688
-6.3%
0.00%0.0%
Q2 2020$258,000
-27.1%
2,870
-19.1%
0.00%0.0%
Q1 2020$354,000
-4.3%
3,548
+10.4%
0.00%0.0%
Q4 2019$370,000
-10.2%
3,213
-1.8%
0.00%0.0%
Q3 2019$412,000
+4.6%
3,271
-0.2%
0.00%0.0%
Q2 2019$394,000
+44.3%
3,278
+5.1%
0.00%0.0%
Q1 2019$273,000
-38.7%
3,119
-29.8%
0.00%0.0%
Q4 2018$445,000
-42.7%
4,445
-34.4%
0.00%
-50.0%
Q3 2018$777,000
-18.4%
6,779
-36.2%
0.00%
-33.3%
Q2 2018$952,000
-33.6%
10,620
-45.8%
0.00%
-25.0%
Q1 2018$1,433,000
+13.7%
19,582
-9.7%
0.00%0.0%
Q4 2017$1,260,000
+16.9%
21,684
-9.8%
0.00%
+33.3%
Q3 2017$1,078,000
+23.2%
24,028
+8.5%
0.00%0.0%
Q2 2017$875,000
-2.0%
22,154
+0.6%
0.00%0.0%
Q1 2017$893,000
+5.3%
22,013
+4.3%
0.00%0.0%
Q4 2016$848,000
+9.6%
21,096
-1.2%
0.00%0.0%
Q3 2016$774,000
+21.1%
21,363
-3.2%
0.00%
+50.0%
Q2 2016$639,000
-0.5%
22,061
+20.2%
0.00%
-33.3%
Q1 2016$642,000
+28.9%
18,357
+18.9%
0.00%
+50.0%
Q4 2015$498,000
-9.6%
15,435
-9.5%
0.00%0.0%
Q3 2015$551,000
-25.0%
17,053
-4.0%
0.00%
-33.3%
Q2 2015$735,000
-6.7%
17,767
+1.2%
0.00%0.0%
Q1 2015$788,000
+43.0%
17,551
+19.2%
0.00%
+50.0%
Q4 2014$551,000
+11.3%
14,728
+3.9%
0.00%0.0%
Q3 2014$495,000
-14.1%
14,170
-13.2%
0.00%0.0%
Q2 2014$576,000
+4.5%
16,328
-3.5%
0.00%0.0%
Q1 2014$551,000
-26.4%
16,912
-4.9%
0.00%
-33.3%
Q4 2013$749,000
+7.0%
17,776
+1.3%
0.00%0.0%
Q3 2013$700,000
-6.7%
17,546
-3.3%
0.00%0.0%
Q2 2013$750,00018,1390.00%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders